Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes
Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes |
https://doi.org/10.18632/oncotarget.27135
Cestmir Altaner,
Ursula Altanerova,
and Jana Jakubechova
|
5573-5575 |
Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone
Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone |
https://doi.org/10.18632/oncotarget.27159
Balaji Krishnamachary,
Dharmalingam Subramaniam,
Prasad Dandawate,
Sivapriya Ponnurangam,
Pugazhendhi Srinivasan,
Prabhu Ramamoorthy,
Shahid Umar,
Sufi Mary Thomas,
Animesh Dhar,
Seth Septer,
Scott J. Weir,
Thomas Attard,
and Shrikant Anant
|
5576-5591 |
Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma
Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma |
https://doi.org/10.18632/oncotarget.27172
Yuzan Kudo,
Shiro Kohi,
Keiji Hirata,
Michael Goggins,
and Norihiro Sato
|
5592-5604 |
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial |
https://doi.org/10.18632/oncotarget.27188
Rajnish Nagarkar,
Darshana Patil,
Timothy Crook,
Vineet Datta,
Sagar Bhalerao,
Sonal Dhande,
Vijay Palwe,
Shirsendu Roy,
Prakash Pandit,
Ashwini Ghaisas,
Raymond Page,
Harjeetsingh Kathuria,
Ajay Srinivasan,
and Dadasaheb Akolkar
|
5605-5621 |
Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosomes has antineoplastic effects for gallbladder cancer
Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosomes has antineoplastic effects for gallbladder cancer |
https://doi.org/10.18632/oncotarget.27193
Hidehiko Hishikawa,
Masaki Kaibori,
Takumi Tsuda,
Kosuke Matsui,
Tadayoshi Okumura,
Eiichi Ozeki,
and Kengo Yoshii
|
5622-5631 |
Impact of exosomal HIV-1 Tat expression on the human cellular proteome
Impact of exosomal HIV-1 Tat expression on the human cellular proteome |
https://doi.org/10.18632/oncotarget.27207
Huafei Lu,
Xiaoli Tang,
Mitchell Sibley,
Jillian Coburn,
R. Shyama Prasad Rao,
Nagib Ahsan,
and Bharat Ramratnam
|
5632-5644 |
Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma
Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma |
https://doi.org/10.18632/oncotarget.27210
Kwang Woon Kim,
Julia Y. Kim,
Jingbo Qiao,
Rachael A. Clark,
Camille M. Powers,
Hernan Correa,
and Dai H. Chung
|
5645-5659 |
Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials
Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials |
https://doi.org/10.18632/oncotarget.27177
Taylor R. Cushman,
Vivek Verma,
Rahul Khairnar,
Joseph Levy,
Charles B. Simone 2nd,
and Mark V. Mishra
|
5660-5668 |
Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine |
https://doi.org/10.18632/oncotarget.27216
Deok-Beom Jung,
Miyong Yun,
Eun-Ok Kim,
Jaekwang Kim,
Bonglee Kim,
Ji Hoon Jung,
Enfeng Wang,
Debabrata Mukhopadhyay,
Edward Hammond,
Keith Dredge,
Viji Shridhar,
and Sung-Hoon Kim
|
5669-5669 |
Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development
Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development |
https://doi.org/10.18632/oncotarget.27218
Laura Molina,
Hong Yang,
Adeola O. Adebayo Michael,
Michael Oertel,
Aaron Bell,
Sucha Singh,
Xin Chen,
Junyan Tao,
and Satdarshan P. Monga
|
5670-5670 |